Cardiopulmonary Exercise Testing in Hypertrophic Cardiomyopathy: Refining a Proven Tool for Better Risk Prognostication

meta-analysis in this issue of the Journal of the American Heart Association ( JAHA ). They explore the usefulness of CPET variables in the risk assessment and prognostic ascertainment of adverse outcomes in HCM. 6 The meta-analysis included a systematic search of eligible studies of CPET and HCM in databases through 2023 comprising 60 full-length articles and 12 914 patients (predominantly men; mean age, 48–50 years)

• Publication year

  2025

• Venue

  Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease

• Publication date

  2025-08-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/JAHA.125.044210PMID 40878974PMCID 12553412
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiopulmonary Exercise Testing for Characterization of Hypertrophic Cardiomyopathy: A Meta‐Analysis

  2025cited by this paper
• Cardiopulmonary exercise testing parameters in healthy athletes vs. equally fit individuals with hypertrophic cardiomyopathy.

  2025cited by this paper
• 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

  2024cited by this paper
• Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption

  2023cited by this paper
• 2023 ESC Guidelines for the management of cardiomyopathies.

  2023cited by this paper
• Cardiopulmonary Exercise Testing in Athletes With Hypertrophic Cardiomyopathy.

  2022cited by this paper
• Clinical Implications of the New York Heart Association Classification

  2019cited by this paper
• Long‐term outcomes for different surgical strategies to treat left ventricular outflow tract obstruction in hypertrophic cardiomyopathy

  2018cited by this paper
• Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy.

  2016cited by this paper
• Heart Failure Progression in Hypertrophic Cardiomyopathy　- Possible Insights From Cardiopulmonary Exercise Testing.

  2016cited by this paper
• Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment.

  2015cited by this paper
• Cardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy

  2015cited by this paper
• Mechanisms and medical management of exercise intolerance in hypertrophic cardiomyopathy.

  2014cited by this paper
• Hypertrophic cardiomyopathy

  2013cited by this paper
• Chronotropic incompetence and its relation to exercise intolerance in hypertrophic cardiomyopathy.

  2011cited by this paper
• Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.

  2009cited by this paper
• Exercise haemodynamic variables rather than ventilatory efficiency indexes contribute to risk assessment in chronic heart failure patients treated with carvedilol.

  2009cited by this paper
• Long term exercise capacity in patients with hypertrophic cardiomyopathy treated with percutaneous transluminal septal myocardial ablation

  2008cited by this paper
• Ventilatory efficiency and resting hemodynamics in hypertrophic cardiomyopathy.

  2008cited by this paper
• Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes.

  2002cited by this paper
• Hypertrophic cardiomyopathy.

  1994cited by this paper
• Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.

  1992cited by this paper

• No citing papers are available for this paper.